Dose-escalation study of chemoradiotherapy of three-dimensional conformal radiotherapy (3D-CRT) with accelerated hyperfractionation (AHF) and concurrent chemotherapy (cisplatin and vinorelbine) for unresectable stage III non-small cell lung cancer (NSCLC).
N. Yoshimura
No relevant relationships to disclose
S. Kudoh
No relevant relationships to disclose
H. Tanaka
No relevant relationships to disclose
N. Sizumira
No relevant relationships to disclose
T. Kimura
No relevant relationships to disclose
S. Mitsuoka
No relevant relationships to disclose
T. Tada
No relevant relationships to disclose
M. H. Hosono
No relevant relationships to disclose
K. Hirata
No relevant relationships to disclose